Efficacy of Oral Sodium Tungstate (200 mg/Day) on Weight Loss in Subjects With Grade I-II Obesity
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2016
At a glance
- Drugs Sodium tungstate (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Acronyms TROTA-1
- 02 Apr 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Oct 2009 Results presented at the 2009 Annual Meeting of the North American Association for the Study of Obesity (NAASO 2009).
- 23 Jul 2008 The expected completion date for this trial has been extended from May 2008 to May 2009, as reported by ClinicalTrials.gov.